C7A.1

The ICD-10-CM code for malignant poorly differentiated neuroendocrine tumors is C7A.1. The full clinical description is "Malignant poorly differentiated neuroendocrine tumors". C7A.1 is a billable/specific code that can be used on insurance claims and medical billing.

ICD-10-CM code C7A.1 represents “Malignant poorly differentiated neuroendocrine tumors”. It is classified under Chapter 2: Neoplasms and is a billable/specific code that can be used on a claim.

Yes, C7A.1 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

C7A.1 is in Chapter 2: Neoplasms (codes C00-D49).

Yes, when using C7A.1, also report: any associated endocrine syndrome, such as:; carcinoid syndrome (E34.00).

C7A.1 is linked to 3 UMLS Concept Unique Identifiers: C2349334, C2349333, C2349335. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like malignant poorly differentiated neuroendocrine tumors affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

There is no direct ICD-11 mapping available for C7A.1 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.